 WATERTOWN, Mass., June 28, 2021 GLOBE NEWSWIRE -- EyePoint Pharmaceuticals, Inc. NASDAQ: EYPT, a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced today that the Company will be added to the small-cap Russell 2000 Index and the broad-market Russell 3000 Index effective after the US market opens on June 28, 2021 as a result of the annual Russell index reconstitution. 